129 related articles for article (PubMed ID: 15389127)
1. Relationship between endothelin and the pathophysiology of tissue factor-induced and lipopolysaccharide-induced disseminated intravascular coagulation in rats: a study examining the effect of an endothelin receptor antagonist.
Suga Y; Asakura H; Yoshida T; Omote M; Ontachi Y; Mizutani T; Yamazaki M; Morishita E; Nakao S; Miyamoto K
Blood Coagul Fibrinolysis; 2004 Oct; 15(7):593-8. PubMed ID: 15389127
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of urokinase on lipopolysaccharide-induced disseminated intravascular coagulation in rats: focus on organ function and endothelin levels.
Asakura H; Asamura R; Ontachi Y; Hayashi T; Omote M; Arahata M; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Yoshida T; Miyamoto K; Nakao S
Thromb Haemost; 2005 Apr; 93(4):724-8. PubMed ID: 15841319
[TBL] [Abstract][Full Text] [Related]
3. Selective inducible nitric oxide synthase inhibition attenuates organ dysfunction and elevated endothelin levels in LPS-induced DIC model rats.
Asakura H; Asamura R; Ontachi Y; Hayashi T; Yamazaki M; Morishita E; Miyamoto KI; Nakao S
J Thromb Haemost; 2005 May; 3(5):1050-5. PubMed ID: 15869603
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats.
Asakura H; Suga Y; Yoshida T; Ontachi Y; Mizutani T; Kato M; Ito T; Morishita E; Yamazaki M; Miyamoto K; Nakao S
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):221-8. PubMed ID: 12695743
[TBL] [Abstract][Full Text] [Related]
5. Induction of vasoactive substances differs in LPS-induced and TF-induced DIC models in rats.
Asakura H; Okudaira M; Yoshida T; Ontachi Y; Yamazaki M; Morishita E; Miyamoto K; Nakao S
Thromb Haemost; 2002 Oct; 88(4):663-7. PubMed ID: 12362240
[TBL] [Abstract][Full Text] [Related]
6. Significance of decreased plasma D-dimer levels following lipopolysaccharide-induced disseminated intravascular coagulation in rats.
Asakura H; Sano Y; Omote M; Yoshida T; Ontachi Y; Mizutani T; Kaneda M; Yamazaki M; Morishita E; Takami A; Miyamoto K; Nakao S
Int J Hematol; 2004 May; 79(4):394-9. PubMed ID: 15218973
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin preparations attenuate organ dysfunction and hemostatic abnormality by suppressing the production of cytokines in lipopolysaccharide-induced disseminated intravascular coagulation in rats.
Asakura H; Takahashi Y; Kubo A; Ontachi Y; Hayashi T; Omote M; Arahata M; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Takami A; Yoshida T; Miyamoto K; Nakao S
Crit Care Med; 2006 Sep; 34(9):2421-5. PubMed ID: 16810104
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of low-molecular-weight heparin against lipopolysaccharide-induced disseminated intravascular coagulation in rats is abolished by coadministration of tranexamic acid.
Asakura H; Sano Y; Yoshida T; Omote M; Ontachi Y; Mizutani T; Yamazaki M; Morishita E; Takami A; Miyamoto K; Nakao S
Intensive Care Med; 2004 Oct; 30(10):1950-5. PubMed ID: 15480547
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models.
Asakura H; Ichino T; Yoshida T; Suga Y; Ontachi Y; Mizutani T; Kato M; Ito T; Yamazaki M; Aoshima K; Morishita E; Saito M; Miyamoto KI; Nakao S
Blood Coagul Fibrinolysis; 2002 Apr; 13(3):233-9. PubMed ID: 11943937
[TBL] [Abstract][Full Text] [Related]
10. Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
Thromb Haemost; 1994 Sep; 72(3):392-6. PubMed ID: 7855790
[TBL] [Abstract][Full Text] [Related]
11. Marked difference in pathophysiology between tissue factor- and lipopolysaccharide-induced disseminated intravascular coagulation models in rats.
Asakura H; Suga Y; Aoshima K; Ontachi Y; Mizutani T; Kato M; Saito M; Morishita E; Yamazaki M; Takami A; Miyamoto K; Nakao S
Crit Care Med; 2002 Jan; 30(1):161-4. PubMed ID: 11902257
[TBL] [Abstract][Full Text] [Related]
12. Urinary protein C inhibitor as a therapeutic agent to disseminated intravascular coagulation (DIC): a comparison with low molecular weight heparin in rats with lipopolysaccharide-induced DIC.
Izutani W; Fujita M; Nishizawa K; Koga J
Biol Pharm Bull; 2000 Sep; 23(9):1046-50. PubMed ID: 10993202
[TBL] [Abstract][Full Text] [Related]
13. Salvianolic acid A alleviates lipopolysaccharide-induced disseminated intravascular coagulation by inhibiting complement activation.
Zhang QY; Guo J; Xu L; Wei Y; Zhou ST; Lu QY; Guo L; Sun QY
BMC Complement Med Ther; 2022 Sep; 22(1):245. PubMed ID: 36127691
[TBL] [Abstract][Full Text] [Related]
14. Effect of activated human protein C on disseminated intravascular coagulation induced by lipopolysaccharide in rats.
Aoki Y; Ota M; Katsuura Y; Komoriya K; Nakagaki T
Arzneimittelforschung; 2000 Sep; 50(9):809-15. PubMed ID: 11050697
[TBL] [Abstract][Full Text] [Related]
15. No interplay between the pathways mediating coagulation and inflammation in tissue factor-induced disseminated intravascular coagulation in rats.
Ontachi Y; Asakura H; Takahashi Y; Hayashi T; Arahata M; Kadohira Y; Maekawa M; Omote M; Yoshida T; Yamazaki M; Morishita E; Miyamoto K; Nakao S
Crit Care Med; 2006 Oct; 34(10):2646-50. PubMed ID: 16932226
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effect of the active form of vitamin D3 against LPS-induced DIC but not against tissue-factor-induced DIC in rat models.
Asakura H; Aoshima K; Suga Y; Yamazaki M; Morishita E; Saito M; Miyamoto K; Nakao S
Thromb Haemost; 2001 Feb; 85(2):287-90. PubMed ID: 11246549
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of DX-9065a, an orally active, novel synthesized and selective inhibitor of factor Xa, against thromboplastin-induced experimental disseminated intravascular coagulation in rats.
Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
Semin Thromb Hemost; 1996; 22(3):255-9. PubMed ID: 8836010
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: possible role of PAF in tissue factor generation.
Kawamura M; Terashita Z; Imura Y; Shino A; Nishikawa K
Thromb Res; 1993 May; 70(4):281-93. PubMed ID: 8332959
[TBL] [Abstract][Full Text] [Related]
19. The effects of higenamine on LPS-induced experimental disseminated intravascular coagulation (DIC) in rats.
Yun-Choi HS; Pyo MK; Chang KC; Lee DH
Planta Med; 2002 Apr; 68(4):326-9. PubMed ID: 11988856
[TBL] [Abstract][Full Text] [Related]
20. Pre-treatment with bone marrow-derived mesenchymal stem cells inhibits systemic intravascular coagulation and attenuates organ dysfunction in lipopolysaccharide-induced disseminated intravascular coagulation rat model.
Wang B; Wu SM; Wang T; Liu K; Zhang G; Zhang XQ; Yu JH; Liu CZ; Fang CC
Chin Med J (Engl); 2012 May; 125(10):1753-9. PubMed ID: 22800895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
